Keywords: routine, reopro, use, justified, eli, lilly/centocor, abciximab

Routine ReoPro use "cannot be justified"

Article | 07 September 1999

Print This

Eli Lilly/Centocor's ReoPro (abciximab) does not need to be used inall coronary stenting cases and its routine use cannot ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in